Cheplapharm Arzneimittel €780 million refinancing

16/7/2018
Refinancing

€ 780 million

$ 912 million

Announced

16/7/2018


Overview:

  • The refinancing consists of a €530 million seven years term loan and a €250 million six years revolving credit facility.
  • Deutsche Bank, HSBC and Unicredit acted as bookrunners.
  • Cheplapharm Arzneimittel is a German manufacturer of pharmaceutical products.

Mihail Georgiev - Data analyst

 

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in